Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

AKTX holding history

Akari Therapeutics Plc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKTX overviewAll 13F holders of AKTXFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of AKTX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−17,415−100.0%Sold outHolders
Q2 202517,415$20.4K<0.1%−969−5.3%ReducedHolders
Q1 202518,384$22.8K<0.1%−5,081−21.7%ReducedHolders
Q4 202423,465$28.6K<0.1%+5,396+29.9%AddedHolders
Q3 202418,069$53.3K<0.1%+1,000+5.9%AddedHolders
Q2 202417,069$46.1K<0.1%+2,300+15.6%AddedHolders
Q1 202414,769$28.0K<0.1%+4,500+43.8%AddedHolders
Q4 202310,269$32.0K<0.1%−7,200−41.2%ReducedHolders
Q3 202317,469$69.0K<0.1%+1,557+9.8%AddedConverted for a 1-for-20 splitHolders
Q2 2023318,250$54.0K<0.1%+34,700+12.2%AddedHolders
Q1 2023283,550$52.0K<0.1%+228,100+411.4%AddedHolders
Q4 202255,450$26.0K<0.1%+15,400+38.5%AddedHolders
Q3 202240,050$25.0K<0.1%−5,900−12.8%ReducedHolders
Q2 202245,950$46.0K<0.1%−300−0.6%ReducedHolders
Q1 202246,250$56.0K<0.1%−14,039−23.3%ReducedHolders
Q4 202160,289$90.0K<0.1%−5,061−7.7%ReducedHolders
Q3 202165,350$107.0K<0.1%−86,046−56.8%ReducedHolders
Q2 2021151,396$262.0K<0.1%+18,645+14.0%AddedHolders
Q1 2021132,751$350.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.